Oklahoma Board of Pharmacy Inspector's Desk--Compounders Beware

From The Inspector’s Desk
♦ 13.32. Compounders Beware: All compounded products
that contain hydrocodone should be treated as Schedule II
drugs. This would require a hard copy prescription written
by the physician. Since these products are not Food and
Drug Administration (FDA) approved, Drug Enforcement
Administration (DEA) states that its rule is to go with the
higher schedule for the compound. The Code of Federal
Regulations that DEA operates under is based solely on
FDA approval.
♦ 13.33. Physician Agents: Nursing home and hospice
employees must be “agents of the physician” to call in
controlled prescriptions to pharmacies. The physician must
use a form to designate who may call in prescriptions on
his or her behalf. A sample form may be found at www
.pharmacy.ok.gov under “Forms for Download” and then
“Pharmacies.” DEA recommends that the original agreement be
kept by the practitioner during the term of the
relationship and for a reasonable time after revocation.
A signed copy should be provided to the practitioner’s
designated agent, his or her employer, and any pharmacies
that regularly receive communications from the agent
pursuant to the agreement. Non-controlled prescriptions
are not required to have this agreement, but the pharmacists
are required to exercise due diligence on all prescriptions.
♦ 13.34. CDS Prescriptions Put on Hold: If a controlled
prescription is put on hold, the original prescription must
be pulled when it is filled so the date of filling and pharmacist’s initials
may be recorded.

quoted from Oklahoma Board of Pharmacy October 2013 Newsletter